Top Industry Leaders in the Bone Pain Treatment Market
Latest Bone Pain Treatment Companies Updates:
Eli Lilly and Company (US) Announced positive Phase 3 data for its tanezumab antibody drug for osteoarthritis pain, potentially offering a longer-lasting alternative to opioids (August 2023).
Amgen Received FDA approval for its Evenity™ (romosozumab) injection for the treatment of osteoporosis in postmenopausal women at high risk for fracture (September 2023).
Medtronic plc (Ireland) Launched its Intellis™ Spinal Cord Stimulation System with advanced features for personalized pain relief in chronic back and leg pain (October 2023).
Baxter International Received CE Mark approval for its Mobi-C™ vertebral augmentation system for minimally invasive treatment of painful vertebral compression fractures (November 2023).
Regeneron Pharmaceuticals Partnered with Bone Therapeutics to develop and commercialize bone anabolic therapy for osteoporosis patients (December 2023).
List of Bone Pain Treatment Key companies in the market:
- Eli Lilly
- Amneal Pharmaceuticals LLC.
- Actavis plc
- Novartis International AG
- Marksans Pharma
- Amgen, Inc.
- Debiopharm Group
- Pfizer, Inc.
- Eli Lilly
- Boston Scientific
- Venus Remedies Ltd.